Bionet (1784) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.013x

Based on the latest financial reports, Bionet (1784) has a cash flow conversion efficiency ratio of 0.013x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$28.46 Million ≈ $896.68K USD) by net assets (NT$2.26 Billion ≈ $71.12 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Review Bionet leverage flexibility ratio to assess the company's free cash flow relative to its total liabilities.

Bionet - Cash Flow Conversion Efficiency Trend (2017–2025)

This chart illustrates how Bionet's cash flow conversion efficiency has evolved over time, based on yearly financial data. Also see 1784 stock market capitalisation for the company's overall valuation and market capitalisation.

Bionet Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bionet ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Loop Telecommunication International Inc TW:3025	0.069x
Petrolimex Insurance Corp VN:PGI	0.060x
Hurriyet Gazetecilik ve Matbaacilik AS IS:HURGZ	-0.435x
Logistic Properties of the Americas NYSE MKT:LPA	0.009x
Kron Telekomunikasyon Hizmetleri AS IS:KRONT	0.156x
Champion Building Materials Co Ltd TW:1806	0.048x
M & A EQUITY HOLDINGS BERHAD KLSE:7082	-0.069x
New Fortress Energy LLC NASDAQ:NFE	-0.026x

Annual Cash Flow Conversion Efficiency for Bionet (2017–2025)

The table below shows the annual cash flow conversion efficiency of Bionet from 2017 to 2025. View Bionet share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	NT$2.26 Billion ≈ $71.12 Million	NT$148.04 Million ≈ $4.66 Million	0.066x	-10.97%
2024-12-31	NT$2.40 Billion ≈ $75.48 Million	NT$176.49 Million ≈ $5.56 Million	0.074x	-17.13%
2023-12-31	NT$1.72 Billion ≈ $54.26 Million	NT$153.09 Million ≈ $4.82 Million	0.089x	+24.41%
2022-12-31	NT$1.32 Billion ≈ $41.74 Million	NT$94.65 Million ≈ $2.98 Million	0.071x	+577.37%
2021-12-31	NT$1.32 Billion ≈ $41.45 Million	NT$13.88 Million ≈ $437.23K	0.011x	-81.54%
2020-12-31	NT$1.29 Billion ≈ $40.62 Million	NT$73.66 Million ≈ $2.32 Million	0.057x	+2698.56%
2019-12-31	NT$1.31 Billion ≈ $41.19 Million	NT$2.67 Million ≈ $84.09K	0.002x	+121.09%
2018-12-31	NT$1.34 Billion ≈ $42.22 Million	NT$-12.97 Million ≈ $-408.78K	-0.010x	+46.69%
2017-12-31	NT$1.37 Billion ≈ $43.21 Million	NT$-24.91 Million ≈ $-784.83K	-0.018x	--

About Bionet

TWO:1784 Taiwan Diagnostics & Research

Market Cap

$97.95 Million

NT$3.11 Billion TWD

Market Cap Rank

#19288 Global

#1083 in Taiwan

Share Price

NT$61.80

Change (1 day)

+2.66%

52-Week Range

NT$56.10 - NT$115.50

All Time High

NT$161.50